We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
+0.93%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$138M
AUM Growth
-$9.31M
Cap. Flow
-$9.71M
Cap. Flow %
-7.03%
Top 10 Hldgs %
24.49%
Holding
191
New
28
Increased
25
Reduced
77
Closed
34

Top Buys

Rank Stock Value
1
TSN icon
Tyson Foods
TSN
+$935K
2
MET icon
MetLife
MET
+$903K
3
FOX icon
Fox Class B
FOX
+$867K
4
CAG icon
Conagra Brands
CAG
+$770K
5
ELAN icon
Elanco Animal Health
ELAN
+$663K

Sector Composition

Rank Sector Weight
1 Healthcare 19.04%
2 Consumer Staples 15.56%
3 Industrials 14.75%
4 Technology 13.52%
5 Financials 12.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FL
51
DELISTED
Foot Locker
FL
$905K 0.66%
20,975
-550
-3% -$22.1K
ABBV icon
52
AbbVie
ABBV
$465B
$896K 0.65%
11,830
+4,750
+67% +$326K
MET icon
53
MetLife
MET
$62.4B
$894K 0.65%
+18,950
New +$903K
CRL icon
54
Charles River Laboratories
CRL
$13B
$890K 0.64%
6,725
-250
-4% -$33.5K
GOOG icon
55
Alphabet (Google) Class C
GOOG
$4.18T
$873K 0.63%
14,320
OSK icon
56
Oshkosh
OSK
$8.84B
$849K 0.61%
11,200
+5,750
+106% +$440K
TFC icon
57
Truist Financial
TFC
$61.6B
$847K 0.61%
15,875
-450
-3% -$22.3K
ELAN icon
58
Elanco Animal Health
ELAN
$11.5B
$840K 0.61%
31,600
+22,100
+233% +$663K
EL icon
59
Estee Lauder
EL
$34.8B
$830K 0.6%
4,170
-7,380
-64% -$1.41M
CAG icon
60
Conagra Brands
CAG
$7.21B
$821K 0.59%
+26,750
New +$770K
PEP icon
61
PepsiCo
PEP
$185B
$814K 0.59%
5,938
+200
+3% +$26.6K
FOX icon
62
Fox Class B
FOX
$25.4B
$792K 0.57%
+25,100
New +$867K
STI
63
DELISTED
SunTrust Banks, Inc.
STI
$791K 0.57%
11,490
-2,750
-19% -$176K
MDT icon
64
Medtronic
MDT
$120B
$787K 0.57%
7,250
-550
-7% -$57.4K
VIRT icon
65
Virtu Financial
VIRT
$5.12B
$781K 0.57%
47,718
-8,000
-14% -$160K
CIEN icon
66
Ciena
CIEN
$47.4B
$766K 0.55%
19,530
+12,155
+165% +$510K
GIS icon
67
General Mills
GIS
$19.6B
$745K 0.54%
13,525
MCD icon
68
McDonald's
MCD
$179B
$723K 0.52%
3,367
UNH icon
69
UnitedHealth
UNH
$337B
$717K 0.52%
3,300
-525
-14% -$127K
CME icon
70
CME Group
CME
$98.9B
$714K 0.52%
3,380
+2,150
+175% +$449K
PRAH
71
DELISTED
PRA Health Sciences, Inc.
PRAH
$707K 0.51%
7,121
-950
-12% -$94.3K
ADI icon
72
Analog Devices
ADI
$175B
$682K 0.49%
6,100
-5,925
-49% -$671K
CL icon
73
Colgate-Palmolive
CL
$69.4B
$661K 0.48%
8,988
-100
-1% -$7.25K
CRM icon
74
Salesforce
CRM
$210B
$649K 0.47%
4,370
-50
-1% -$7.6K
TRN icon
75
Trinity Industries
TRN
$2.24B
$640K 0.46%
32,500
-1,100
-3% -$20.8K

Similar funds

New England Research & Management's Q3 2019 Portfolio in Review

As of Q3 2019, New England Research & Management held 191 positions worth $138M, down 6.3% from $147M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

New England Research & Management withdrew a net $9.71M in Q3 2019, closing 34 positions and reducing 77 holdings. Its most notable exit was Amgen, an estimated $1.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, New England Research & Management opened a new position in Tyson Foods worth $948K.

  • New England Research & Management's largest Q3 2019 buy was Tyson Foods: 11,000 shares worth $948K.
  • New England Research & Management added most to Elanco Animal Health in Q3 2019, an estimated $663K increase.
  • New England Research & Management's biggest Q3 2019 reduction was Estee Lauder, cutting an estimated $1.41M.
  • New England Research & Management fully exited Amgen in Q3 2019, selling an estimated $1.8M.
  • New England Research & Management's ten largest holdings make up 24% of its $138M portfolio in Q3 2019.
  • New England Research & Management opened 28 new positions and closed 34 in Q3 2019.
  • New England Research & Management's portfolio value fell 6.3% quarter-over-quarter to $138M.

Based on New England Research & Management's 13F filing for Q3 2019, filed 4 Nov 2019.